{
    "title": "Reverse Voxsplaining: Drugs vs. Chairs",
    "date": "August 29, 2016",
    "links": [
        "https://slatestarcodex.com/2015/09/24/the-problems-with-generic-medications-go-deeper-than-one-company/",
        "http://marginalrevolution.com/marginalrevolution/2015/09/generic-drug-regulation.html",
        "https://mises.org/blog/lack-epipen-competitors-fdas-fault",
        "http://www.cnbc.com/2016/08/25/the-fda-and-congress-share-the-blame-for-outrageous-epipen-prices-commentary.html",
        "https://www.statnews.com/pharmalot/2016/08/25/senators-fda-epipen-rivals/",
        "http://www.washingtonexaminer.com/fda-partly-to-blame-in-epipen-price-debacle/article/2600315",
        "http://gizmodo.com/how-congress-the-fda-and-sarah-jessica-parker-helped-1785568792",
        "http://lfb.org/epipens-price-surge-fda-capitalism/",
        "http://www.vox.com/2016/8/23/12608316/epipen-price-mylan",
        "http://www.ncbi.nlm.nih.gov/pubmed/12806434",
        "http://money.cnn.com/2016/08/26/investing/epipen-price-hike-generic-alternative/",
        "http://richmondbizsense.com/2012/08/14/whats-in-a-name-plenty-of-cash/",
        "http://www.fda.gov/Safety/Recalls/ucm469980.htm",
        "http://www.fiercepharma.com/marketing/still-no-epipen-challenge-sight-for-mylan-as-another-competitor-hits-a-snag",
        "https://en.wikipedia.org/wiki/Epinephrine_autoinjector#History",
        "https://slatestarcodex.com/2016/08/29/reverse-voxsplaining-drugs-vs-chairs/#comment-403086",
        "http://adrenaclick.com/",
        "http://abcnews.go.com/Health/epipen-users-options-generic-alternate-drugs/story?id=41667390",
        "https://www.opensecrets.org/lobby/clientsum.php?id=D000027765",
        "https://www.opensecrets.org/lobby/clientbills.php?id=D000027765&year=2013",
        "http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/09/lather-rinse-repeat-senators-take-another-stab-at-passing-the-preserve-access-to-affordable-generics.html",
        "http://www.telegraph.co.uk/news/health/news/8855924/Deaths-from-bee-stings-chair-falls-and-boiling-water.html"
    ],
    "url": "https://slatestarcodex.com/2016/08/29/reverse-voxsplaining-drugs-vs-chairs/",
    "summary": "Key ideas\n- EpiPens, medical devices that help reverse allergic reactions, have recently increased significantly in price.\n- The issue with the pharmaceutical industry is not lack of regulation like in other industries, but rather that it is part of a complex cronyist system.\n- Potential competitors of the EpiPen all got rejected by the FDA for various reasons.\n- EpiPens are not interchangeable with their competitors, meaning doctors must prescribe EpiPen-brand EpiPens.\n- The government is having trouble allowing a generic alternative to EpiPen due to factors like pharmaceutical companies lobbying against affordable generics.\n\nKey learnings\n- The pharmaceutical industry is not subject to the same free-market principles as other industries.\n- The FDA plays a significant role in permitting generic alternatives for medications.\n- Pharmaceutical companies often spend significant amounts of money on lobbying.\n\nKey questions\n- Why did the FDA reject potential competitors of the EpiPen?\n- Why are EpiPens not interchangeable with other affordable alternatives?\n- What can be done to address the complex cronyist system within the pharmaceutical industry?\n- What other medications are affected by similar issues with patents and regulations?"
}